Sutro Biopharma (STRO) FCF Margin (2017 - 2026)
Sutro Biopharma's FCF Margin came in at -228.55% for Q4 2025, up 263.09 percentage points from -491.63% a year earlier and up 168.03 percentage points from the prior quarter.
Powered by 
Analysis
Sutro Biopharma (STRO) FCF Margin (2017 - 2026) Analysis & Trends
For FY2025, Sutro Biopharma's FCF Margin was -174.59%, up 139.13 percentage points from FY2024.
- FCF Margin carries a five-year change of +0.80 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -313.71% in FY2024 (-238.30 pp), -75.41% in FY2023 (-69.05 pp), -6.36% in FY2022 (+150.40 pp) and -156.76% in FY2021 (+18.63 pp).
- The five-year range for quarterly FCF Margin is -766.95% (Q3 2024) to 258.94% (Q3 2022).
- Year-over-year, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of -12.48 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q3 2022 (a gain of 604.17 percentage points), and the weakest in Q3 2024 (a drop of 567.05 percentage points).
- Business Quant data shows STRO's FCF Margin at -396.57% (Q3 2025), -70.30% (Q2 2025) and -396.90% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 28.96% |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | -389.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -389.17% |
| Mar 31, 2026 | -291.06% |
| Dec 31, 2025 | -228.55% |
| Sep 30, 2025 | -396.57% |
| Jun 30, 2025 | -70.30% |
| Mar 31, 2025 | -396.90% |
| Dec 31, 2024 | -491.63% |
| Sep 30, 2024 | -766.95% |
| Jun 30, 2024 | 33.84% |
| Mar 31, 2024 | -501.13% |
| Dec 31, 2023 | 11.11% |
| Sep 30, 2023 | -199.89% |
| Jun 30, 2023 | -315.01% |
| Mar 31, 2023 | -488.66% |
| Dec 31, 2022 | -315.47% |
| Sep 30, 2022 | 258.94% |
| Jun 30, 2022 | -19.17% |
| Mar 31, 2022 | -624.18% |
| Dec 31, 2021 | -226.37% |
| Sep 30, 2021 | -345.23% |
API Access
Sutro Biopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();